retatrutide fat loss clinical trial results First phase 3 data, a Triumph of Science! ⚠️ BEWARE OF RETATRUTIDE SOLD

Among women with PCOS, semaglutide or tirzepatide prescribing increased from 2.4% in 2021 to 17.6% in 2025, a more than 7-fold increase

"Its modulation may reduce sexual desire in some patients." "Common adverse effects, such as nausea, fatigue or malaise, as well as psychological adjustment to rapid weight loss, can indirectly decrease sexual desire."

Tip: Always consult with your healthcare provider to ensure you use the correct needle for your specific injection technique

Near normalisation of blood glucose improves the potentiating effect of GLP-1 on glucose-induced insulin secretion in patients with type 2 diabetes

A study by Ida et al